244 related articles for article (PubMed ID: 38108069)
1. Antihypertensives associated adverse events: a review of mechanisms and pharmacogenomic biomarkers available evidence in multi-ethnic populations.
Altoum SM; Al-Mahayri ZN; Ali BR
Front Pharmacol; 2023; 14():1286494. PubMed ID: 38108069
[TBL] [Abstract][Full Text] [Related]
2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
3. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
4. Pharmacotherapy for hypertension-induced left ventricular hypertrophy.
Leache L; Gutiérrez-Valencia M; Finizola RM; Infante E; Finizola B; Pardo Pardo J; Flores Y; Granero R; Arai KJ
Cochrane Database Syst Rev; 2021 Oct; 10(10):CD012039. PubMed ID: 34628642
[TBL] [Abstract][Full Text] [Related]
5. Hypertension in African Populations: Review and Computational Insights.
Mabhida SE; Mashatola L; Kaur M; Sharma JR; Apalata T; Muhamed B; Benjeddou M; Johnson R
Genes (Basel); 2021 Apr; 12(4):. PubMed ID: 33917487
[TBL] [Abstract][Full Text] [Related]
6. Hypertension pharmacogenomics: in search of personalized treatment approaches.
Cooper-DeHoff RM; Johnson JA
Nat Rev Nephrol; 2016 Feb; 12(2):110-22. PubMed ID: 26592190
[TBL] [Abstract][Full Text] [Related]
7. An update on the pharmacogenetics of treating hypertension.
Fontana V; Luizon MR; Sandrim VC
J Hum Hypertens; 2015 May; 29(5):283-91. PubMed ID: 25355012
[TBL] [Abstract][Full Text] [Related]
8. Toxicity and Pharmacogenomic Biomarkers in Breast Cancer Chemotherapy.
Al-Mahayri ZN; Patrinos GP; Ali BR
Front Pharmacol; 2020; 11():445. PubMed ID: 32351390
[TBL] [Abstract][Full Text] [Related]
9. Withdrawal of antihypertensive drugs in older people.
Reeve E; Jordan V; Thompson W; Sawan M; Todd A; Gammie TM; Hopper I; Hilmer SN; Gnjidic D
Cochrane Database Syst Rev; 2020 Jun; 6(6):CD012572. PubMed ID: 32519776
[TBL] [Abstract][Full Text] [Related]
10. Pharmacogenomics of Antihypertensive Drugs in Brazil: Recent Progress and Clinical Implications.
Vecchia Genvigir FD; Dagli-Hernandez C; Hirata TDC; Zhou Y; Lauschke VM; Hirata MH; Hirata RDC
Endocr Metab Immune Disord Drug Targets; 2022; 22(13):1263-1275. PubMed ID: 34951375
[TBL] [Abstract][Full Text] [Related]
11. Pharmacogenetics of antihypertensive drug responses.
Schwartz GL; Turner ST
Am J Pharmacogenomics; 2004; 4(3):151-60. PubMed ID: 15174896
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of pharmacogenomic variants in 100 pharmacogenes among Southeast Asian populations under the collaboration of the Southeast Asian Pharmacogenomics Research Network (SEAPharm).
Runcharoen C; Fukunaga K; Sensorn I; Iemwimangsa N; Klumsathian S; Tong H; Vo NS; Le L; Hlaing TM; Thant M; Zain SM; Mohamed Z; Pung YF; Capule F; Nevado J; Silao CL; Al-Mahayri ZN; Ali BR; Yuliwulandari R; Prayuni K; Zahroh H; Noor DAM; Xangsayarath P; Xayavong D; Kounnavong S; Sayasone S; Kordou Z; Liopetas I; Tsikrika A; Tsermpini EE; Koromina M; Mitropoulou C; Patrinos GP; Kesornsit A; Charoenyingwattana A; Wattanapokayakit S; Mahasirimongkol S; Mushiroda T; Chantratita W
Hum Genome Var; 2021 Feb; 8(1):7. PubMed ID: 33542200
[TBL] [Abstract][Full Text] [Related]
13. Adverse Cardiovascular Outcomes and Antihypertensive Treatment: A Genome-Wide Interaction Meta-Analysis in the International Consortium for Antihypertensive Pharmacogenomics Studies.
McDonough CW; Warren HR; Jack JR; Motsinger-Reif AA; Armstrong ND; Bis JC; House JS; Singh S; El Rouby NM; Gong Y; Mychaleckyj JC; Rotroff DM; Benavente OR; Caulfield MJ; Doria A; Pepine CJ; Psaty BM; Glorioso V; Glorioso N; Hiltunen TP; Kontula KK; Arnett DK; Buse JB; Irvin MR; Johnson JA; Munroe PB; Wagner MJ; Cooper-DeHoff RM
Clin Pharmacol Ther; 2021 Sep; 110(3):723-732. PubMed ID: 34231218
[TBL] [Abstract][Full Text] [Related]
14. Multi-gene Pharmacogenomic Testing That Includes Decision-Support Tools to Guide Medication Selection for Major Depression: A Health Technology Assessment.
Ontario Health (Quality)
Ont Health Technol Assess Ser; 2021; 21(13):1-214. PubMed ID: 34484487
[TBL] [Abstract][Full Text] [Related]
15. The future of antihypertensive treatment.
Israili ZH; Hernández-Hernández R; Valasco M
Am J Ther; 2007; 14(2):121-34. PubMed ID: 17414579
[TBL] [Abstract][Full Text] [Related]
16. Pharmacogenomic studies of hypertension: paving the way for personalized antihypertensive treatment.
Eadon MT; Kanuri SH; Chapman AB
Expert Rev Precis Med Drug Dev; 2018; 3(1):33-47. PubMed ID: 29888336
[TBL] [Abstract][Full Text] [Related]
17. Sepsis Care Pathway 2019.
Labib A
Qatar Med J; 2019; 2019(2):4. PubMed ID: 31763206
[No Abstract] [Full Text] [Related]
18. Expanding role of pharmacogenomics in the management of cardiovascular disorders.
Yip VL; Pirmohamed M
Am J Cardiovasc Drugs; 2013 Jun; 13(3):151-62. PubMed ID: 23579966
[TBL] [Abstract][Full Text] [Related]
19. ACE-Inhibitors in Hypertension: A Historical Perspective and Current Insights.
Cutrell S; Alhomoud IS; Mehta A; Talasaz AH; Van Tassell B; Dixon DL
Curr Hypertens Rep; 2023 Sep; 25(9):243-250. PubMed ID: 37284934
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
